RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $177,377 | +143.6% | 164,238 | +190.9% | 0.03% | +130.8% |
Q2 2023 | $72,827 | -82.6% | 56,455 | -82.2% | 0.01% | -85.2% |
Q1 2023 | $418,163 | +1233.5% | 316,790 | +1415.3% | 0.09% | +1157.1% |
Q4 2022 | $31,359 | -94.0% | 20,906 | -95.3% | 0.01% | -94.6% |
Q3 2022 | $525,000 | +226.1% | 444,719 | +212.8% | 0.13% | +97.0% |
Q2 2022 | $161,000 | +436.7% | 142,187 | +1294.5% | 0.07% | +407.7% |
Q1 2022 | $30,000 | -73.9% | 10,196 | -76.4% | 0.01% | -80.0% |
Q4 2021 | $115,000 | -28.1% | 43,256 | +17.3% | 0.06% | +20.4% |
Q2 2021 | $160,000 | – | 36,878 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |